Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression
Bone Marrow Transplantation, Published online: 07 February 2024; doi:10.1038/s41409-024-02219-0Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - February 7, 2024 Category: Hematology Authors: Barbara Meissner Peter Lang Peter Bader Manfred Hoenig Ingo M üller Roland Meisel Johann Greil Martin G. Sauer Markus Metzler Selim Corbacioglu Birgit Burkhardt Matthias W ölfl Brigitte Strahm Kinan Kafa Oliver Basu Holger N. Lode Bernd Gruhn Holger Car Source Type: research
The effect of center experience on allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia
Bone Marrow Transplantation, Published online: 06 February 2024; doi:10.1038/s41409-024-02222-5The effect of center experience on allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - February 6, 2024 Category: Hematology Authors: Masamitsu Yanada Shingo Yano Yachiyo Kuwatsuka Koji Kawamura Takahiro Fukuda Tatsuo Ichinohe Yoshiko Hashii Hideki Goto Koji Kato Fumihiko Ishimaru Atsushi Sato Makoto Onizuka Keitaro Matsuo Yuri Ito Atsumi Yanagisawa Marie Ohbiki Ken Tabuchi Yoshiko Atsu Source Type: research
Cost analysis of patients undergoing allogeneic stem cell transplantation or chimeric antigen receptor T-cell therapy in relapsed or refractory diffuse large B-cell lymphoma from a German healthcare payer perspective
Bone Marrow Transplantation, Published online: 06 February 2024; doi:10.1038/s41409-024-02228-zCost analysis of patients undergoing allogeneic stem cell transplantation or chimeric antigen receptor T-cell therapy in relapsed or refractory diffuse large B-cell lymphoma from a German healthcare payer perspective (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - February 6, 2024 Category: Hematology Authors: P. Ahmadi S. Ghandili F. Jakobs C. Konnopka A. Morgner-Miehlke N. Kr öger F. Ayuk Source Type: research
Graft-versus-host disease and impact on relapse in myelofibrosis undergoing hematopoietic stem cell transplantation
Bone Marrow Transplantation, Published online: 06 February 2024; doi:10.1038/s41409-024-02220-7Graft-versus-host disease and impact on relapse in myelofibrosis undergoing hematopoietic stem cell transplantation (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - February 6, 2024 Category: Hematology Authors: Sofia Oechsler Nico Gagelmann Christine Wolschke Dietlinde Janson Anita Badbaran Evgeny Klyuchnikov Radwan Massoud Kristin Rathje Johanna Richter Mathias Sch äfersküpper Christian Niederwieser Ameya Kunte Silke Heidenreich Francis Ayuk Nicolaus Kr öger Source Type: research
Dual T cell depletion for graft versus host disease prevention in peripheral blood haploidentical hematopoietic cell transplantation for adults with hematological malignancies
Bone Marrow Transplantation, Published online: 05 February 2024; doi:10.1038/s41409-024-02216-3Dual T cell depletion for graft versus host disease prevention in peripheral blood haploidentical hematopoietic cell transplantation for adults with hematological malignancies (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - February 5, 2024 Category: Hematology Authors: Tommy Alfaro Moya Maria Queralt Salas Abel Santos Carreira Eshetu G. Atenafu Arjun Datt Law Wilson Lam Ivan Pasic Dennis (Dong Hwan) Kim Fotios V. Michelis Igor Novitzky Basso Armin Gerbitz Jeffrey Howard Lipton Rajat Kumar Jonas Mattsson Auro Viswabandya Source Type: research
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT
Bone Marrow Transplantation, Published online: 31 January 2024; doi:10.1038/s41409-023-02160-8In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - January 31, 2024 Category: Hematology Authors: Meral Beksac Diderik-Jan Eikema Linda Koster Cyrille Hulin Xavier Poir é Rose-Marie Hamladji Tomasz Gromek Ali Bazarbachi Zubeyde Nur Ozkurt Thomas Pabst Tarek Ben Othman J ürgen Finke Olga Pirogova Depei Wu Amjad Hayat Inken Hilgendorf Eleni Tholouli L Source Type: research
Diagnostic evaluation in bone marrow failure disorders: what have we learnt to help inform the transplant decision in 2024 and beyond?
Bone Marrow Transplantation, Published online: 30 January 2024; doi:10.1038/s41409-024-02213-6Diagnostic evaluation in bone marrow failure disorders: what have we learnt to help inform the transplant decision in 2024 and beyond? (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - January 30, 2024 Category: Hematology Authors: Giulia Ciangola Enrico Santinelli Donal P. McLornan Simona Pagliuca Carmelo Gurnari Source Type: research
Utility of the refined EBMT diagnostic and severity criteria 2023 for sinusoidal obstruction syndrome/veno-occlusive disease
Bone Marrow Transplantation, Published online: 29 January 2024; doi:10.1038/s41409-024-02215-4Utility of the refined EBMT diagnostic and severity criteria 2023 for sinusoidal obstruction syndrome/veno-occlusive disease (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - January 29, 2024 Category: Hematology Authors: Hiroya Ichikawa Kimikazu Yakushijin Keiji Kurata Takahiro Tsuji Naoko Takemoto Miki Joyce Yuri Okazoe Ruri Takahashi Sakuya Matsumoto Rina Sakai Akihito Kitao Yoshiharu Miyata Yasuyuki Saito Shinichiro Kawamoto Katsuya Yamamoto Mitsuhiro Ito Tohru Murayam Source Type: research
Sequential haplo-identical conditioning transplant regimen for pediatric patients with relapsed or refractory hemophagocytic lymphohistiocytosis
Bone Marrow Transplantation, Published online: 29 January 2024; doi:10.1038/s41409-024-02212-7Sequential haplo-identical conditioning transplant regimen for pediatric patients with relapsed or refractory hemophagocytic lymphohistiocytosis (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - January 29, 2024 Category: Hematology Authors: Yan Yue Shifen Fan Zhouyang Liu Fan Jiang Jiao Chen Jiayue Qin Yuan Sun Source Type: research
Correction: Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study
Bone Marrow Transplantation, Published online: 26 January 2024; doi:10.1038/s41409-023-02194-yCorrection: Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - January 26, 2024 Category: Hematology Authors: Dawn Maze Murat O. Arcasoy Ryan Henrie Sonia Cerquozzi Rammurti Kamble Samer Al-Hadidi Abdulraheem Yacoub Anurag K. Singh Mahmoud Elsawy Shireen Sirhan Elliot Smith Curtis Marcoux Auro Viswabandya Andrew Daly Hassan Sibai Caroline McNamara Yuliang Shi Wei Source Type: research
Letermovir for Cytomegalovirus infection in pediatric patients undergoing allogenic hematopoietic stem cell transplantation: a real-life study by the Infectious Diseases Working Group of Italian Association of Pediatric Hematology-Oncology (AIEOP)
Bone Marrow Transplantation, Published online: 25 January 2024; doi:10.1038/s41409-024-02209-2Letermovir for Cytomegalovirus infection in pediatric patients undergoing allogenic hematopoietic stem cell transplantation: a real-life study by the Infectious Diseases Working Group of Italian Association of Pediatric Hematology-Oncology (AIEOP) (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - January 25, 2024 Category: Hematology Authors: Federica Galaverna Francesco Baccelli Daniele Zama Gloria Tridello Riccardo Masetti Elena Soncini Rossella Mura Federica Barzaghi Antonella Colombini Giulia Prunotto Maria Rosaria D ’Amico Elisabetta Calore Alessandra Biffi Katia Perruccio Pietro Gasper Source Type: research
Out of specification Tisagenlecleucel is associated with outcomes comparable to standard of care product in relapsed or refractory diffuse large B-cell lymphoma
Bone Marrow Transplantation, Published online: 25 January 2024; doi:10.1038/s41409-024-02205-6Out of specification Tisagenlecleucel is associated with outcomes comparable to standard of care product in relapsed or refractory diffuse large B-cell lymphoma (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - January 25, 2024 Category: Hematology Authors: Chiara De Philippis Cristina Zucchinetti Daniele Mannina Mauro Krampera Pier Luigi Zinzani Annalisa Chiappella Alice di Rocco Enrico Orcioulo Maria Chiara Tisi Flavio Pistolese Laura Giordano Armando Santoro Stefania Bramanti Source Type: research
A prognostic score system in adult T‐cell acute lymphoblastic leukemia after hematopoietic stem cell transplantation
Bone Marrow Transplantation, Published online: 24 January 2024; doi:10.1038/s41409-024-02211-8A prognostic score system in adult T‐cell acute lymphoblastic leukemia after hematopoietic stem cell transplantation (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - January 24, 2024 Category: Hematology Authors: Mengyu Xiao Jianying Zhou Xiaolu Zhu Yun He Fengrong Wang Yuanyuan Zhang Xiaodong Mo Wei Han Jingzhi Wang Yu Wang Huan Chen Yuhong Chen Xiangyu Zhao Yingjun Chang Lanping Xu Kaiyan Liu Xiaojun Huang Xiaohui Zhang Source Type: research
Donor NKG2D rs1049174 polymorphism predicts hematopoietic recovery and event-free survival after single-unit cord blood transplantation in adults
Bone Marrow Transplantation, Published online: 24 January 2024; doi:10.1038/s41409-024-02217-2Donor NKG2D rs1049174 polymorphism predicts hematopoietic recovery and event-free survival after single-unit cord blood transplantation in adults (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - January 24, 2024 Category: Hematology Authors: Takaaki Konuma Megumi Hamatani-Asakura Maki Monna-Oiwa Seiko Kato Masamichi Isobe Kazuaki Yokoyama Yasuhito Nannya Satoshi Takahashi Source Type: research
Letermovir prophylaxis lowers the incidence of Non-CMV infections after allogeneic hematopoietic cell transplantation
Bone Marrow Transplantation, Published online: 23 January 2024; doi:10.1038/s41409-024-02201-wLetermovir prophylaxis lowers the incidence of Non-CMV infections after allogeneic hematopoietic cell transplantation (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - January 23, 2024 Category: Hematology Authors: Saffiya Z. Bashey Scott R. Solomon Xu Zhang Lawrence E. Morris H. Kent Holland Lizamarie Bachier Melhem M. Solh Source Type: research
